{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T22:25:18Z","timestamp":1768083918570,"version":"3.49.0"},"reference-count":19,"publisher":"American Academy of Pediatrics (AAP)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,5,1]]},"abstract":"<jats:p>Thiamine transporter-2 deficiency is a recessive disease caused by mutations in the SLC19A3 gene. Patients manifest acute episodes of encephalopathy; symmetric lesions in the cortex, basal ganglia, thalami or periaqueductal gray matter, and a dramatic response to biotin or thiamine. We report a 30-day-old patient with mutations in the SLC19A3 gene who presented with acute encephalopathy and increased level of lactate in the blood (8.6 mmol\/L) and cerebrospinal fluid (7.12 mmol\/L), a high excretion of \u03b1-ketoglutarate in the urine, and increased concentrations of the branched-chain amino acids leucine and isoleucine in the plasma. MRI detected bilateral and symmetric cortico-subcortical lesions involving the perirolandic area, bilateral putamina, and medial thalami. Some lesions showed low apparent diffusion coefficient values suggesting an acute evolution; others had high values likely to be subacute or chronic, most likely related to the perinatal period. After treatment with thiamine and biotin, irritability and opisthotonus disappeared, and the patient recovered consciousness. Biochemical disturbances also disappeared within 48 hours. After discontinuing biotin, the patient remained stable for 6 months on thiamine supplementation (20 mg\/kg\/day). The examination revealed subtle signs of neurologic sequelae, and MRI showed necrotic changes and volume loss in some affected areas. Our observations suggest that patients with thiamine transporter 2 deficiency may be vulnerable to metabolic decompensation during the perinatal period, when energy demands are high. Thiamine defects should be excluded in newborns and infants with lactic acidosis because prognosis largely depends on the time from diagnosis to thiamine supplementation.<\/jats:p>","DOI":"10.1542\/peds.2012-2988","type":"journal-article","created":{"date-parts":[[2013,4,16]],"date-time":"2013-04-16T00:54:20Z","timestamp":1366073660000},"page":"e1670-e1675","source":"Crossref","is-referenced-by-count":61,"title":["Reversible Lactic Acidosis in a Newborn With Thiamine Transporter-2 Deficiency"],"prefix":"10.1542","volume":"131","author":[{"given":"Bel\u00e9n","family":"P\u00e9rez-Due\u00f1as","sequence":"first","affiliation":[{"name":"Departments of Child Neurology,"},{"name":"Centre for Biomedical Research on Rare Diseases (CIBER-ER), Instituto de Salud Carlos III, Barcelona, Spain; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mercedes","family":"Serrano","sequence":"additional","affiliation":[{"name":"Centre for Biomedical Research on Rare Diseases (CIBER-ER), Instituto de Salud Carlos III, Barcelona, Spain; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00f3nica","family":"Rebollo","sequence":"additional","affiliation":[{"name":"Radiology,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jordi","family":"Muchart","sequence":"additional","affiliation":[{"name":"Radiology,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Gargallo","sequence":"additional","affiliation":[{"name":"Pediatrics, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Celine","family":"Dupuits","sequence":"additional","affiliation":[{"name":"Unit\u00e9 fonctionnelle neurom\u00e9tabolique, H\u00f4pital Piti\u00e9-Salp\u00eatri\u00e8re, Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael","family":"Artuch","sequence":"additional","affiliation":[{"name":"Centre for Biomedical Research on Rare Diseases (CIBER-ER), Instituto de Salud Carlos III, Barcelona, Spain; and"},{"name":"Clinical Biochemistry, Hospital Sant Joan de D\u00e9u, Universitat de Barcelona, Barcelona, Spain;"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"417","published-online":{"date-parts":[[2013,5,1]]},"reference":[{"issue":"1","key":"2021120900105950800_B1","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1086\/431216","article-title":"Biotin-responsive basal ganglia disease maps to 2q36.3 and is due to mutations in SLC19A3.","volume":"77","author":"Zeng","year":"2005","journal-title":"Am J Hum Genet"},{"issue":"pt 7","key":"2021120900105950800_B2","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1093\/brain\/121.7.1267","article-title":"Biotin-responsive basal ganglia disease: a novel entity.","volume":"121","author":"Ozand","year":"1998","journal-title":"Brain"},{"issue":"1","key":"2021120900105950800_B3","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1001\/archneurol.2009.293","article-title":"Biotin-responsive basal ganglia disease in ethnic Europeans with novel SLC19A3 mutations.","volume":"67","author":"Debs","year":"2010","journal-title":"Arch Neurol"},{"issue":"10","key":"2021120900105950800_B4","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1002\/mds.25008","article-title":"Reversible generalized dystonia and encephalopathy from thiamine transporter 2 deficiency.","volume":"27","author":"Serrano","year":"2012","journal-title":"Mov Disord"},{"issue":"17","key":"2021120900105950800_B5","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1056\/NEJMc0809100","article-title":"Mutations in a thiamine-transporter gene and Wernicke\u2019s-like encephalopathy.","volume":"360","author":"Kono","year":"2009","journal-title":"N Engl J Med"},{"key":"2021120900105950800_B6","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/1471-2350-11-171","article-title":"A wide spectrum of clinical and brain MRI findings in patients with SLC19A3 mutations.","volume":"11","author":"Yamada","year":"2010","journal-title":"BMC Med Genet"},{"issue":"3","key":"2021120900105950800_B7","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/10372","article-title":"Mutations in SLC19A2 cause thiamine-responsive megaloblastic anaemia associated with diabetes mellitus and deafness.","volume":"22","author":"Labay","year":"1999","journal-title":"Nat Genet"},{"issue":"3","key":"2021120900105950800_B8","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1093\/jn\/129.3.641","article-title":"Dietary thiamin level influences levels of its diphosphate form and thiamin-dependent enzymic activities of rat liver.","volume":"129","author":"Blair","year":"1999","journal-title":"J Nutr"},{"issue":"2","key":"2021120900105950800_B9","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0167-4838(98)00069-7","article-title":"Thiamin metabolism and thiamin diphosphate-dependent enzymes in the yeast Saccharomyces cerevisiae: genetic regulation.","volume":"1385","author":"Hohmann","year":"1998","journal-title":"Biochim Biophys Acta"},{"issue":"6","key":"2021120900105950800_B10","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.ajhg.2011.11.007","article-title":"Thiamine pyrophosphokinase deficiency in encephalopathic children with defects in the pyruvate oxidation pathway.","volume":"89","author":"Mayr","year":"2011","journal-title":"Am J Hum Genet"},{"issue":"7","key":"2021120900105950800_B11","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1002\/ajmg.a.33373","article-title":"Amish microcephaly: long-term survival and biochemical characterization.","volume":"152A","author":"Siu","year":"2010","journal-title":"Am J Med Genet A"},{"issue":"1\u20133","key":"2021120900105950800_B12","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1385\/MN:31:1-3:017","article-title":"Role of mitochondrial dysfunction and oxidative stress in the pathogenesis of selective neuronal loss in Wernicke\u2019s encephalopathy.","volume":"31","author":"Desjardins","year":"2005","journal-title":"Mol Neurobiol"},{"issue":"5","key":"2021120900105950800_B13","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1542\/peds.2007-3502","article-title":"Mitochondrial oxidative phosphorylation disorders presenting in neonates: clinical manifestations and enzymatic and molecular diagnoses.","volume":"122","author":"Gibson","year":"2008","journal-title":"Pediatrics"},{"issue":"9\u201310","key":"2021120900105950800_B14","first-page":"843","article-title":"A rare case of severe lactic acidosis in a preterm infant: lack of thiamine during total parenteral nutrition.","volume":"24","author":"Oguz","year":"2011","journal-title":"J Pediatr Endocrinol Metab"},{"key":"2021120900105950800_B15","doi-asserted-by":"crossref","first-page":"e233","DOI":"10.1542\/peds.2004-1255","article-title":"Outbreak of life-threatening thiamine deficiency in infants in Israel caused by a defective soy-based formula.","volume":"115(2)","author":"Fattal-Valevski","year":"2005","journal-title":"Pediatrics"},{"issue":"1","key":"2021120900105950800_B16","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1053\/j.semperi.2009.10.004","article-title":"Applications of positron emission tomography in the newborn nursery.","volume":"34","author":"Kannan","year":"2010","journal-title":"Semin Perinatol"},{"issue":"3","key":"2021120900105950800_B17","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.neuint.2010.11.019","article-title":"Modeling neurodegenerative disease pathophysiology in thiamine deficiency: consequences of impaired oxidative metabolism.","volume":"58","author":"Jhala","year":"2011","journal-title":"Neurochem Int"},{"issue":"6","key":"2021120900105950800_B18","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s00234-009-0604-x","article-title":"Neuroimaging findings in pediatric Wernicke encephalopathy: a review.","volume":"52","author":"Zuccoli","year":"2010","journal-title":"Neuroradiology"},{"issue":"5","key":"2021120900105950800_B19","doi-asserted-by":"crossref","first-page":"C851","DOI":"10.1152\/ajpcell.00105.2006","article-title":"Biotin-responsive basal ganglia disease-linked mutations inhibit thiamine transport via hTHTR2: biotin is not a substrate for hTHTR2.","volume":"291","author":"Subramanian","year":"2006","journal-title":"Am J Physiol Cell Physiol"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/131\/5\/e1670\/1091624\/peds_2012-2988.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/131\/5\/e1670\/1091624\/peds_2012-2988.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,9]],"date-time":"2021-12-09T05:42:03Z","timestamp":1639028523000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/131\/5\/e1670\/31295\/Reversible-Lactic-Acidosis-in-a-Newborn-With"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5,1]]},"references-count":19,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2013,5,1]]},"published-print":{"date-parts":[[2013,5,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2012-2988","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,5,1]]}}}